In morning trade the Creso Pharma Ltd (ASX: CPH) share price is storming higher following the release of an announcement.
At the time of writing, the cannabis company’s shares are up 13% to 26 cents.
What did Creso Pharma announce?
This morning the company announced that it has completed all required importing and exporting procedures and successfully delivered a second shipment of its cannaQIX products to Pharma Dynamics South Africa.
CannaQIX is Creso Pharma’s range of cannabidiol (CBD) hemp oil-based nutraceuticals. These products contain a broad spectrum of organic hemp oil extracts with CBD that aims to improve management of stress and to support mental and nervous functions.
This delivery follows the receipt of a second purchase order from Pharma Dynamics in October valued at CHF220,000 (~A$320,000).
Management notes that this money has now been banked and adds to Creso Pharma’s growing revenue profile.
What’s next?
The company advised that it is confident that additional opportunities will materialise in Africa in the coming months. It continues to work with Pharma Dynamics to establish a broader footprint in the region and anticipates purchase orders to grow in size and volume.
Management commented: “Creso is extremely pleased with the swift timing of the second PO and delivery, demonstrating a healthy relationship and positive patient response. Creso believes there will be more POs from this region in a sustainable way. This underpins Creso’s current global growth trajectory and its entry into new markets towards a recurring revenue model.”
Balance sheet update.
As of 31 December 2020, Creso Pharma had a cash balance of over $6 million. Since then, the company has received an additional $1.7 million following the exercise of options. Management believes this provides it with the cash required to fund its expansion into new markets.
Furthermore, it believes its balance sheet gives it the foundation to continue to win market share as well as to be in a position to easily capitalise any potential further international growth opportunities.
This Tiny ASX Stock Could Be the Next Afterpay
One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…
Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.
Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!
See how you can find out the name of this stock
Returns as of 6th October 2020
More reading
- Why ASX cannabis shares are cheering the US elections
- Why Accent, Afterpay, Creso Pharma, & Thorn shares are charging higher
- Why the Creso Pharma (ASX:CPH) share price rocketed 47% higher
- Here are 3 ASX small cap shares with exciting product launches in 2021
- Why the Creso Pharma (ASX:CPH) share price is jumping 9% higher
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Here’s why the Creso Pharma (ASX:CPH) share price is jumping 13% higher today appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3q5ZXmA
Leave a Reply